
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Cushing's syndrome classification
Introduction
Overview
Overview
Cushing’s syndrome may be classified according to the source of cortisol into four subtypes; Endogenous, exogenous, familial Cushing’s Syndrome, and pseudo-Cushing’s syndrome.
Classification
Classification
Cushing’s syndrome is classified into two main subtypes:[1][2][3]
- Exogenous:
- Also called iatrogenic Cushing’s syndrome. It is due to chronic glucocorticoid intake for inflammatory conditions, such as allergies, asthma, autoimmune diseases, and after organ transplantation.
- Endogenous:
-
- Pituitary adenoma
- Adrenal adenoma
- Adrenal micronodular hyperplasia
- Ectopic adenomas, which are originated from locations other than the pituitary or adrenal glands, mostly from the lungs, pancreas, thyroid, or thymus.
- Malignant tumors:
- Adrenal cancer
- Cancer in places other than the pituitary or adrenal glands, mostly in the lungs, pancreas, thyroid, or thymus
-
- Familial Cushing’s Syndrome:
- Patients with rare genetic diseases like multiple endocrine neoplasia type 1 (MEN 1) and primary pigmented micronodular adrenal disease are more susceptible to develop tumors in glands that affect cortisol secretion. As a result, these patients will develop Cushing’s syndrome.
- Pseudo-Cushing’s Syndrome:
- It is due to alcoholism, depression or other psychiatric disorders, obesity, pregnancy, and poorly controlled diabetes.
References
References
- ↑ Lacroix A, Feelders RA, Stratakis CA, Nieman LK (2015). “Cushing’s syndrome”. Lancet. 386 (9996): 913–27. doi:10.1016/S0140-6736(14)61375-1. PMID 26004339.
- ↑ Raff H, Carroll T (2015). “Cushing’s syndrome: from physiological principles to diagnosis and clinical care”. J. Physiol. (Lond.). 593 (3): 493–506. doi:10.1113/jphysiol.2014.282871. PMC 4324701. PMID 25480800.
- ↑ Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD (2014). “Adrenocortical carcinoma”. Endocr. Rev. 35 (2): 282–326. doi:10.1210/er.2013-1029. PMC 3963263. PMID 24423978.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Furqan M M. M.B.B.S[3]
